Form 4 for TMO Thermo Fisher Scientific
Accepted 2025-02-05 00:00:00 ET · period of report 2025-02-03 · accession 0001127602-25-003227 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-05 | 2025-02-03+ | TMO | Williamson Stephen | SVP, CFO | M - OptEx | $253.99 | +19.6K | 37.1K | +112% | +$4.99M |
| DM | 2025-02-05 | 2025-02-03+ | TMO | Williamson Stephen | SVP, CFO | S - Sale+OE | $589.36 | -19.6K | 27.3K | -42% | -$11.58M |
| DM | 2025-02-05 | 2025-02-03+ | TMO | Williamson Stephen | SVP, CFO | M - OptEx | $0.00 | -19.6K | 9,825 | -67% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-03 | M | A | 9,825 | $253.99 | 37,120.81 | D | — | — | (F1) On November 15, 2022, the reporting person contributed 18,700 shares of common stock to a grantor retained annuity trust for the benefit of his children. Upon termination of the trust on 12/11/2024, 0 shares were transferred by the trust to the reporting person's children. The remaining 8,844 shares were previously distributed to the reporting person and continue to be reported in this Form 4 as directly owned. |
| 2 | Common | Common Stock | 2025-02-03 | S | D | 9,825 | $593.13 | 27,295.81 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-04 | M | A | 9,825 | $253.99 | 37,120.81 | D | — | — | |
| 4 | Common | Common Stock | 2025-02-04 | S | D | 9,825 | $585.59 | 27,295.81 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-02-04 | M | D | 9,825 | $0.00 | 0 | D | $253.99 · — to 2026-02-26 | 9,825 Common Stock | (F4) The option vested in four equal installments on February 26, 2020, 2021, 2022, and 2023. |
| 6 | Derivative | Stock Option (Right to Buy) | 2025-02-03 | M | D | 9,825 | $0.00 | 9,825 | D | $253.99 · — to 2026-02-26 | 9,825 Common Stock | (F4) The option vested in four equal installments on February 26, 2020, 2021, 2022, and 2023. |